Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCEH1 | Q6PIU2 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL220205 | 0.86 | NCEH1 (0.61) | NCEH1KMT2AMEN1MAPTCYP1A2 | |
| SCHEMBL18037716 | 0.86 | NCEH1 (0.62) | NCEH1KMT2AMEN1MAPTCYP1A2 | |
| SCHEMBL19231594 | 0.85 | HSD17B10 (0.57) | NCEH1MAPTCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL11893003 | 0.83 | KMT2A (0.60) | NCEH1KMT2AMEN1MAPTSMN1; SMN2 | |
| SCHEMBL13244348 | 0.81 | NCEH1 (0.56) | NCEH1KMT2AMEN1MAPTKDM4E | |
| SCHEMBL13888682 | 0.80 | NCEH1 (0.71) | NCEH1KMT2AMAPTKDM4EALDH1A1 | |
| SCHEMBL19002412 | 0.79 | NCEH1 (0.54) | NCEH1KMT2AMEN1CYP2C9TDP1 | |
| SCHEMBL22416830 | 0.78 | MAPT (0.69) | NCEH1KMT2AMEN1MAPTHSD17B10 | |
| SCHEMBL21872049 | 0.77 | NCEH1 (0.52) | NCEH1KMT2AMEN1MAPTKDM4E | |
| SCHEMBL18209496 | 0.77 | ALDH1A1 (0.62) | NCEH1HSD17B10KDM4ETDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023132551-A1 | SAND FOR DIAGNOSING STATE OF ANIMAL URINE, METHOD FOR MANUFACTURING SAME, AND URINE STATE DIAGNOSIS METHOD USING SAME | 주식회사 퓨쳐바이오웍스 | 2023-07-13 | — | — | WO | claimed |
| EP-3237365-B1 | CYCLOALKANE OXIDATION CATALYSTS AND METHOD TO PRODUCE ALCOHOLS AND KETONES | RHODIA OPERATIONS (FR) | 2018-11-28 | — | — | EP | claimed |
| EP-2877439-B1 | CYCLOALKANE OXIDATION CATALYSTS AND METHOD TO PRODUCE ALCOHOLS AND KETONES | RHODIA OPERATIONS (FR) | 2018-02-14 | — | — | EP | claimed |
| US-20170349524-A1 | Cycloalkane oxidation catalysts and method to produce alcohols and ketones | BASF SE (DE) | 2017-12-07 | — | — | US | claimed |
| EP-3237365-A1 | CYCLOALKANE OXIDATION CATALYSTS AND METHOD TO PRODUCE ALCOHOLS AND KETONES | Rhodia Operations (FR) | 2017-11-01 | — | — | EP | claimed |
| US-9745239-B2 | Cycloalkane oxidation catalysts and method to produce alcohols and ketones | RHODIA OPERATIONS (FR) | 2017-08-29 | — | — | US | claimed |
| US-9708238-B2 | Cycloalkane oxidation catalysts and method to produce alcohols and ketones | RHODIA OPERATIONS (FR) | 2017-07-18 | — | — | US | claimed |
| EP-2986585-B1 | CYCLOALKANE OXIDATION CATALYSTS AND METHOD TO PRODUCE ALCOHOLS AND KETONES | RHODIA OPERATIONS (FR) | 2017-06-21 | — | — | EP | claimed |
| WO-2016102343-A1 | CYCLOALKANE OXIDATION CATALYSTS AND METHOD TO PRODUCE ALCOHOLS AND KETONES | RHODIA OPERATIONS (FR) | 2016-06-30 | — | — | WO | claimed |
| US-20160060199-A1 | Cycloalkane oxidation catalysts and method to produce alcohols and ketones | PERFORMANCE POLYAMIDES, SAS (FR) | 2016-03-03 | — | — | US | claimed |
| EP-1490300-A1 | TITANOSILICATE, PROCESS FOR ITS PRODUCTION, AND ITS USE IN PRODUCING OXIDIZED COMPOUND | Showa Denko K.K. (JP) | 2004-12-29 | — | — | EP | claimed |
| US-6759540-B2 | FOR USE AS OXIDATION CATALYST IN OXIDATION REACTION OF A COMPOUND HAVING A CARBON-CARBON DOUBLE BOND AND A OTHER FUNCTIONAL GROUP WHEREIN THE CARBON-CARBON DOUBLE BOND OF COMPOUND IS OXIDIZED BY USING A PEROXIDE AS AN OXIDIZING AGENT | SHOWA DENKO K.K. (JP) | 2004-07-06 | — | — | US | claimed |
| US-20040122243-A1 | Process for oxidizing carbon-carbon double bond and process for producing oxidized compounds | SHOWA DENKO K.K. (JP) | 2004-06-24 | — | — | US | claimed |
| US-20040034258-A1 | Crystalline MWW-type titanosilicate catalyst for producing oxidized compound, production process for the catalyst, and process for producing oxidized compound by using the catalyst | SHOWA DENKO K.K. | 2004-02-19 | — | — | US | claimed |
| WO-2003074421-A1 | TITANOSILICATE, PROCESS FOR ITS PRODUCTION, AND ITS USE IN PRODUCING OXIDIZED COMPOUND | SHOWA DENKO K. K. (JP) | 2003-09-12 | — | — | WO | claimed |
| EP-1324948-A2 | CRYSTALLINE MWW-TYPE TITANOSILICATE, ITS PREPARATION AND USE THEREOF FOR PRODUCING EPOXIDES | Showa Denko K.K. (JP) | 2003-07-09 | — | — | EP | claimed |
| US-20030040649-A1 | Crystalline mww-type titanosilicate catalyst for producing oxidized compound, production process for the catalyst, and process for producing oxidized compound by using the catalyst | SHOWA DENKO K.K. (JP) | 2003-02-27 | — | — | US | claimed |
| US-6500955-B1 | CONDENSING A HALO- QUINOLINE WITH AN ALPHA-PICOLYL DERIVATIVES IN THE PRESENCE OF A SOLVENT AND A PHASE TRANSFER CATALYST AT -10 TO 90 DEGREE C. TO FORM (2,8-BIS (TRIFLUOROMETHYL)-4-QUINOLINYL)-2-PYRIDINYLMETHANONE | NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (IN) | 2002-12-31 | — | — | US | claimed |
| US-20020188129-A1 | ONE POT SYNTHESIS OF [2, 8-BIS (TRIFLUOROMETHYL)-4- QUINOLINYL]2-PYRIDINYLMETHANONE, A MEFLOQUINE INTERMEDIATE | NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (IN) | 2002-12-12 | — | — | US | claimed |
| WO-2002028774-A2 | CRYSTALLINE MWW-TYPE TITANOSILICATE , ITS PREPARATION AND USE THEREOF FOR PRODUCING EPOXIDES | SHOWA DENKO K. K. (JP) | 2002-04-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160060199-A1 | Cycloalkane oxidation catalysts and method to produce alcohols and ketones | CBR3, ADH5, CYP2E1 | NCEH1 1740/4885KMT2A 1470/4885MEN1 4825/4885 |
| US-20020188129-A1 | ONE POT SYNTHESIS OF [2, 8-BIS (TRIFLUOROMETHYL)-4- QUINOLINYL]2-PYRIDINYLMETHANONE, A MEFLOQUINE INTERMEDIATE | EIF2AK2, POLK, QARS1 | NCEH1 4188/4885KMT2A 618/4885MEN1 1530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.